Guidelines For Antithrombotic Therapy - Welcome …
1 Guidelines For Antithrombotic Therapy Last updated December 2003 I. Initiation of Anticoagulant Therapy II. Warfarin Anticoagulation III. Initiation of Oral …
Download Guidelines For Antithrombotic Therapy - Welcome …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Guidelines For Antithrombotic Therapy
www.outcomes-umassmed.org3 I. INITIATION OF ANTICOAGULANT THERAPY A. Fractionated, Low Molecular Weight Heparin (LMWH) (SC Administration) • Lovenox 1 mg/kg (maximum dose 150 mg) every 12h (unstable angina, non-ST elevation
GRACE STANDARD DIAGNOSIS STEMI Non-STEMI …
www.outcomes-umassmed.orgGRACE Variable Definitions – Version of March 2006 Page 1 GRACE STANDARD DIAGNOSIS STEMI New or presumed new ST-elevation >1 mm seen in any location on the index ECG or on any subsequent ECG, together with one or more positive enzymes, based on laboratory ranges in use at each hospital.
Related documents
ACG Clinical Guideline: Management of Patients …
gi.orgcolon can present with melena (black, tarry stools) (5). In addition, hematochezia can be seen in patients with brisk upper gastrointestinal bleeding (UGIB).
NON-VITAMIN K ORAL ANTICOAGULANT REVERSAL
surgicalcriticalcare.net2 Approved 02/06/2013 Revised 02/03/2015 (aPTT), and ecarin clotting time (ECT) (1). Monitoring of anticoagulant activity can be performed using PT and aPTT levels, however, the relation is nonlinear with plasma drug concentration making utilization
PERI OPERATIVE MANAGEMENT OF PATIENTS …
thrombosiscanada.ca© 2013 Thrombosis Canada. Page 2 of 7 The peri-operative management of NOAC-treated patients aims to interrupt anticoagulant therapy so there is no (or minimal)
Emerging Treatment Options for the Reversal of …
www.ashpadvantagemedia.comEmerging Treatment Options for the Reversal of Oral Anticoagulant Therapy Presented as a Midday Symposium at the 47th ASHP Midyear Clinical Meeting and Exhibition Monday, December 3, 2012 Las Vegas, Nevada
NOAC GUIDELINES - NSW Health
www.cec.health.nsw.gov.auNon-Vitamin K Antagonist Oral Anticoagulants (NOAC) Guidelines | Page 5 Clinical Excellence Commission Updated July 2017 1. INTRODUCTION Non-Vitamin K antagonist oral anticoagulants (NOAC) are now widely used in patients with non-valvular atrial
NON-VITAMIN K ORAL ANTICOAGULANT REVERSAL
www.surgicalcriticalcare.net2 Approved 02/06/2013 Revised 02/03/2015, 03/29/2016 INTRODUCTION Alternatives to vitamin K antagonists have begun to emerge as options for patients with hypercoagulable